Sparc1028
Solid Tumor in Advanced Stage
Sun Pharma Advanced Research Company LimitedPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Solid Tumor in Advanced Stage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ad1208 Avelos Therapeutics Inc. | Phase 1/2 | CCC |
Sparc1023 Ii Sun Pharma Advanced Research Company Limited | Phase 1 | CC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →